Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report-Reference-Cited by-同舟云学术

Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report

Published:2022-11 Issue:8 Volume:13 Page:1071-1083
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Christofyllakis Konstantinos,Monteiro Ana Raquel,Cetin Onur,Kos Igor Age,Greystoke Alastair,Luciani Andrea

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference152 articles.

1. Aging, frailty, and chemotherapy;Balducci;Cancer Control,2007

2. Comorbidity and polypharmacy in elderly cancer patients: the significance on treatment outcome and tolerance;Jørgensen;J Geriatr Oncol,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activities;Xenobiotica;2024-08-12

2. Patient Age andEGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study;Anticancer Research;2024-03-27

3. Safety Diagnostic Tool for Non-Small Cell Lung Cancer (NSCLC) Lyophilized Serum;Clinical Cancer Investigation Journal;2024

4. tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer;Cellular Oncology;2023-08-29

5. Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial;Signal Transduction and Targeted Therapy;2023-06-30